Low aortic valve gradient and LV dysfunction are commonly seen in patients undergoing TAVR, but only the former is independently associated with poorer outcomes in the first year following the ...

Transcatheter aortic-valve replacement (TAVR) has revolutionized the treatment of symptomatic aortic stenosis, offering a less invasive alternative to surgery. This procedure was first used in ...

WASHINGTON (May 16, 2016) --Patients with a combination of left ventricular dysfunction and low aortic valve gradient, or reduced force of blood flow through the aortic valve, have higher mortality ...

CHICAGO, IL—The incidence of valve hemodynamic deterioration is approximately 2% at both 30 days and 18 months among patients undergoing transcatheter aortic valve replacement, but the changes in the ...

How Does Blood Pressure Differ in the Iab-Pumped Patient and Which Pressures Should Be Documented? Figure 2 illustrates the familiar arterial pressure waveform representative of the non-IAB-pumped ...

The chance that patients with severe aortic stenosis (AS) will receive aortic valve replacement (AVR) is worse than the flip of a coin, even a decade after the game-changing transcatheter option ...

PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in ...

BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Ltd (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of TAVR and the world’s only balloon-expandable ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...